Status:
UNKNOWN
The Risk of Venous Clotting in Patients After Renal Transplant
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Collaborating Sponsors:
Astellas Pharma Canada, Inc.
Conditions:
Venous Thrombosis
End Stage Renal Failure With Renal Transplant
Eligibility:
All Genders
18+ years
Brief Summary
Clots that develop in the deep veins of the legs or the lungs can result in pain, heart and lung disease and may lead to death if unrecognized or not treated. Risk factors for developing clots include...
Eligibility Criteria
Inclusion
- Patients greater than or equal to 18 years of age admitted to St. Joseph's Healthcare Hamilton for renal transplantation.
Exclusion
- Patients requiring therapeutic and/or bridging anticoagulation pre and post operatively.
- Patients requiring therapeutic anticoagulation preoperatively and anticipate therapeutic anticoagulation postoperatively within 48 hours.
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01413464
Start Date
March 1 2011
End Date
September 1 2013
Last Update
July 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6